Thoratec Corp

More

• RESEARCH ALERT-Thoratec Corp: Credit Suisse raises to neutral Monday, 6 May 2013 | 4:29 AM ET

  *Credit Suisse raises to neutral from underperform. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, Solar stocks Friday, 3 May 2013 | 3:35 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.

• CORRECTED-MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, YRC Worldwide Friday, 3 May 2013 | 2:02 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, YRC Worldwide Friday, 3 May 2013 | 1:29 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **DELCATH SYSTEMS INC, $0.43, down 45 pct. **LINKEDIN CORP, $181.69, down 10 pct.

• CORRECTED-MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Chemed, Vocera, YRC Worldwide Friday, 3 May 2013 | 1:24 PM ET

  **RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Chemed, Vocera, Procera Friday, 3 May 2013 | 11:27 AM ET

  **LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.

• MARKET PULSE-LinkedIn, Arena Pharma, Chemed, Vocera, Procera, Zagg Friday, 3 May 2013 | 10:17 AM ET

  **LINKEDIN CORP, $186.46, down 8 pct. **VIVUS INC, $13.28, up 3 pct. Arena said on Thursday that it pulled its application seeking approval for its anti-obesity treatment Belviq in the European Union, lowering competition for rival Vivus, whose obesity pill was recommended for European approval by regulators late last month.

• MARKET PULSE-LinkedIn, Arena Pharma, Chemed, Blucora, AIG, Regeneron Friday, 3 May 2013 | 8:56 AM ET

  **LINKEDIN CORP, Thursday close $201.67, down 9 pct premarket. **VIVUS INC, Thursday close $12.95, up 4 pct premarket.

• RESEARCH ALERT-Thoratec: Canaccord Genuity cuts target price Friday, 3 May 2013 | 6:12 AM ET

  *Canaccord Genuity cuts target price to $36 from $39; rating hold. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

• RESEARCH ALERT-Thoratec: Oppenheimer cuts target price Friday, 3 May 2013 | 3:29 AM ET

  *Oppenheimer cuts target price to $42 from $43; rating outperform. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

• RESEARCH ALERT-Thoratec: Credit Suisse cuts price target Friday, 3 May 2013 | 2:21 AM ET

  *Credit Suisse cuts price target to $37 from $40. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

• MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Chemed, Vocera, YRC Worldwide Friday, 3 May 2013 | 12:57 AM ET

  **RADCOM LTD, $4.05, up 53 pct. **LINKEDIN CORP, $181.69, down 10 pct. The U.S. Justice Department is suing the company and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.

• MARKET PULSE-MGIC, Pfizer, Nuance Communications, Avon Products Tuesday, 30 Apr 2013 | 8:40 AM ET

  **MGIC INVESTMENT CORP, Monday close $5.48, down 13 pct premarket. **PFIZER INC, Monday close $30.43, down 3 pct premarket. **ZOETIS INC, Monday close $32.66.

• MARKET PULSE-Pfizer, Nuance Communications, Best Buy, MBIA, HeartWare Tuesday, 30 Apr 2013 | 7:44 AM ET

  **PFIZER INC, Monday close $30.43, down 5 pct premarket. **ZOETIS INC, Monday close $32.66. **NUANCE COMMUNICATIONS INC, Monday close $23.3, down 8 pct premarket.

• UPDATE 1-HeartWare loss smaller than expected; shares rise Monday, 29 Apr 2013 | 7:33 PM ET

  April 29- Medical device maker HeartWare International Inc reported a smaller-than-expected first-quarter loss after sales of its heart pump soared 62 percent, sending its shares up 8 percent in after-market trading.

• HeartWare loss smaller than expected; shares rise Monday, 29 Apr 2013 | 5:46 PM ET

  April 29- Medical device maker HeartWare International Inc reported a smaller-than-expected first-quarter loss after sales of its heart pump soared 62 percent, sending its shares up 8 percent after market. Net loss narrowed to $12.9 million, or 87 cents per share, in the quarter ended March 31, from $18.8 million, or $1.33 per share, a year earlier.

• RESEARCH ALERT-Thoratec: Canaccord Genuity raises target price Thursday, 25 Apr 2013 | 6:45 AM ET

  *Canaccord Genuity raises target price to $39 from $37; rating hold. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

• After-Hours Buzz: MW, VRA, ETFC & More Wednesday, 13 Mar 2013 | 5:39 PM ET

  

  Check out which companies are making headlines after the bell Wednesday: